Search
forLearn 2
Research 10 of 196
- 587 Efficacy and Safety of topical KX-826 in Male Subjects with Androgenetic Alopecia:A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Promises and Pitfalls of Regenerative Therapies for Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, and Exosomes
- Bioactive Compound-Loaded Nanocarriers for Hair Growth Promotion: Current Status and Future Perspectives
- Development and Validation of Androgen-induced Hair Loss and Anagen Induction Mouse Models for Pharmacological Evaluation of Anti-Androgenic Agents
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Topical solutions for androgenetic alopecia: evaluating efficacy and safety
- Androgenetic Alopecia: Therapy Update
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
Community 10 of 216
- Consenus on Kx-826/pyrilutamide vs ru58841
- KX-826 and RU58841: do topical anti-androgens work?
- is kx-826 worth it? looking for advice from users
- KX-826 0.5% BID ~2 months monotherapy(?) results
- Pyrludimide (KX-826) actual drug could work better than the cosmetic version
- Why are there no meaningful baseline blood tests for pyrilutamide (KX-826) like there are for finasteride?
- Anyone in India that order Kintors KX-826?
- RU58841 vs. KX-826 vs. CB-03-01
- Could KX-826 become an alternative to finasteride in the future?
- How's your progress on kx-826 (pyrilutamide)?